Serum Bilirubin and Lipoprotein-a: How Are These Associated with Whole Blood Viscosity?

Overview

Journal Redox Rep

Specialties Biochemistry
Biology
Endocrinology

Date 2012 Feb 21

PMID 22340510

Citations 7

Authors

E U Nwose

R S Richards

P Bwititi

E Butkowski

Affiliations

Soon will be listed here.

Abstract

Background: It has been demonstrated that oxidative stress can induce red blood cell rigidity and haemolysis, which in turn can cause hyperviscosity and hyperbilirubinaemia, respectively. However, haemolysis may be associated with a low level of haemoglobin, which reduces whole blood viscosity (WBV). Bilirubin can behave as antioxidant or oxidant, and one uncharted course for diagnostic pathology is how or whether bilirubinaemia and viscosity are associated. Further, oxidative stress is now being assessed using lipoprotein-a (Lp(a)), among other things but whether it is associated with blood viscosity has not been established.

Aim: This study investigates the association and correlation of haemoglobin level and WBV with serum Lp(a) and bilirubin levels in a general population of patients.

Materials And Methods: Sixty-eight cases that were tested for Lp(a), concomitantly with full blood count and liver function, in our archived clinical pathology database were used in this study. WBV levels were determined using a validated formula. Multivariate and univariate analyses as well as correlation were performed.

Results: WBV was found to be significantly associated with bilirubin (P<0.02), but not with Lp(a). Haemoglobin concentration was inversely correlated with Lp(a) (P<0.04), but not with bilirubinaemia.

Conclusion: This pilot study suggests that hyperbilirubinaemia and hyperviscosity are associated and positively correlated. Consideration of whether serum bilirubin (as an indirect index of oxidative stress) can be used in combination with WBV (as index of macrovascular effect of oxidative stress) to assess oxidative damage is recommended.

Citing Articles

Blood Viscosity Changes in Diabetes Mellitus: A 20-Year Bibliometric Review and Future Directions.

Mbah J, Bwititi P, Gyawali P, Nwose E Cureus. 2024; 16(7):e64211.

PMID: 39130872 PMC: 11310740. DOI: 10.7759/cureus.64211.

Relationship between lipoprotein(a) and whole blood reducing viscosity: A cross-sectional study.

Jing S, Zhu H Medicine (Baltimore). 2023; 102(48):e36236.

PMID: 38050213 PMC: 10695618. DOI: 10.1097/MD.0000000000036236.

Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection.

Al-Kuraishy H, Al-Gareeb A, Al-Hamash S, Cavalu S, El-Bouseary M, Sonbol F Front Med (Lausanne). 2022; 9:876017.

PMID: 35783600 PMC: 9247235. DOI: 10.3389/fmed.2022.876017.

Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties.

Al-Kuraishy H, Al-Gareeb A, El-Bouseary M, Sonbol F, El-Saber Batiha G Clin Exp Med. 2022; 23(3):679-688.

PMID: 35608715 PMC: 9128329. DOI: 10.1007/s10238-022-00836-x.

Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank.

Seyed Khoei N, Wagner K, Sedlmeier A, Gunter M, Murphy N, Freisling H Cardiovasc Diabetol. 2022; 21(1):54.

PMID: 35436955 PMC: 9017025. DOI: 10.1186/s12933-022-01484-x.

References

Barghash N, Elewa S, Hamdi E, Barghash A, El Dine R . Role of plasma homocysteine and lipoprotein (a) in coronary artery disease. Br J Biomed Sci. 2004; 61(2):78-83. DOI: 10.1080/09674845.2004.11732648. View

Matteucci E, Giampietro O . Oxidative stress in families of type 1 diabetic patients. Diabetes Care. 2000; 23(8):1182-6. DOI: 10.2337/diacare.23.8.1182. View

Merrill E, GILLILAND E, COKELET G, Shin H, Britten A, WELLS Jr R . Rheology of human blood, near and at zero flow. Effects of temperature and hematocrit level. Biophys J. 1963; 3:199-213. PMC: 1366440. DOI: 10.1016/s0006-3495(63)86816-2. View

Roll E, Christensen T . Formation of photoproducts and cytotoxicity of bilirubin irradiated with turquoise and blue phototherapy light. Acta Paediatr. 2005; 94(10):1448-54. DOI: 10.1111/j.1651-2227.2005.tb01819.x. View

Marcovina S, Albers J, Scanu A, Kennedy H, Giaculli F, Berg K . Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem. 2000; 46(12):1956-67. View

Banerjee D, Wong E, Shin J, Fortmann S, Palaniappan L . Racial and Ethnic Variation in Lipoprotein (a) Levels among Asian Indian and Chinese Patients. J Lipids. 2011; 2011:291954. PMC: 3108091. DOI: 10.1155/2011/291954. View

Ozkan H, Oren H, Tatli M, Ates H, Kumral A, Duman N . Erythroid apoptosis in idiopathic neonatal jaundice. Pediatrics. 2008; 121(5):e1348-51. DOI: 10.1542/peds.2007-2215. View

von Depka M, Nowak-Gottl U, Eisert R, Dieterich C, Barthels M, Scharrer I . Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood. 2000; 96(10):3364-8. View

Danesh J, Collins R, Peto R . Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies. Circulation. 2000; 102(10):1082-5. DOI: 10.1161/01.cir.102.10.1082. View

10.

Srinivasan S, Dahlen G, Jarpa R, Webber L, Berenson G . Racial (black-white) differences in serum lipoprotein (a) distribution and its relation to parental myocardial infarction in children. Bogalusa Heart Study. Circulation. 1991; 84(1):160-7. DOI: 10.1161/01.cir.84.1.160. View

11.

Tamariz L, Young J, Pankow J, Yeh H, Schmidt M, Astor B . Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol. 2008; 168(10):1153-60. PMC: 2581671. DOI: 10.1093/aje/kwn243. View

12.

Mark M, Walter R, Contesse J, Reinhart W . Impairment of blood rheology by cholestatic jaundice in human beings. J Lab Clin Med. 2004; 142(6):391-8. DOI: 10.1016/S0022-2143(03)00156-2. View

13.

Yang Z, Xia K, Wang L, Jia S, Li D, Zhang Z . Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats. Microvasc Res. 2006; 73(2):131-6. DOI: 10.1016/j.mvr.2006.04.008. View

14.

Antonicelli R, Testa R, Bonfigli A, Sirolla C, Pieri C, Marra M . Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension. Clin Exp Med. 2002; 1(3):145-50. DOI: 10.1007/s10238-001-8026-z. View

15.

Tsimikas S, Lau H, Han K, Shortal B, Miller E, Segev A . Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation. 2004; 109(25):3164-70. DOI: 10.1161/01.CIR.0000130844.01174.55. View

16.

Rekhviashvili A, Tsinamdzgvrishvili B, Chkhetia M, Labakhua G . Relationship of 24-hour blood pressure rhythm with endothelial function and blood rheology. Georgian Med News. 2008; (159):21-6. View

17.

Huang C, Chen H, Pan W, Shih T, Kristol D, COPLEY A . Effects of hematocrit on thixotropic properties of human blood. Biorheology. 1987; 24(6):803-10. DOI: 10.3233/bir-1987-24631. View

18.

Stocker R, Keaney Jr J . Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84(4):1381-478. DOI: 10.1152/physrev.00047.2003. View

19.

Richards R, Nwose E, Bwititi P . Biochemical basis of circadian rhythms and diseases: With emphasis on post-traumatic stress disorder. Med Hypotheses. 2011; 77(4):605-9. DOI: 10.1016/j.mehy.2011.06.045. View

20.

Larsson A, Hassan M, Ridefelt P, Axelsson J . Circadian variability of bilirubin in healthy men during normal sleep and after an acute shift of sleep. Chronobiol Int. 2009; 26(8):1613-21. DOI: 10.3109/07420520903398534. View